Composition: Cefixime 200 mg + Clavulanic Acid 125 mg Tablets

Description:
GZABCI-CV 325 combines Cefixime with Clavulanic Acid, making it effective against resistant bacterial strains. It is widely used for respiratory, urinary, and soft tissue infections.

Key Benefits:

• Superior action against antibiotic-resistant bacteria.
• Enhanced efficacy in recurrent infections.
• Trusted combination for both acute and chronic bacterial infections.